From: The healthy behaviours and COVID-19 mortality among Iranian women: a case–control study
Case (n = 261) | Control (n = 515) | Total | ||||
---|---|---|---|---|---|---|
Frequency | % | Frequency | % | chi2 | p value | |
Age categories | ||||||
< 10 | 17 | 6.5 | 2 | 0.4 | 228.24 | < 0.001 |
10–19 | 3 | 1.1 | 21 | 4.1 | ||
20–29 | 9 | 3.4 | 53 | 10.4 | ||
30–39 | 20 | 7.7 | 119 | 23.0 | ||
40–49 | 23 | 8.8 | 148 | 28.6 | ||
50–59 | 44 | 16.9 | 97 | 19.0 | ||
60–69 | 58 | 22.2 | 54 | 10.6 | ||
70–79 | 57 | 21.8 | 20 | 3.9 | ||
> 80 | 30 | 11.5 | 2 | 0.4 | ||
NCDs | ||||||
Chronic disease | 167 | 64.0 | 41 | 7.9 | 278.2 | < 0.001 |
Diabetes | 94 | 36.01 | 65 | 12.6 | 58.2 | < 0.001 |
CVDs | 120 | 46.1 | 32 | 6.2 | 174.4 | < 0.001 |
Obese | 106 | 40.6 | 24 | 4.6 | 161.2 | < 0.001 |
Metabolic disease | 7 | 2.7 | 2 | 0.4 | 7.99 | 0.005 |
Lung disease | 25 | 9.6 | 26 | 5.0 | 5.86 | 0.015 |
Smoking | ||||||
Yes | 2 | 0.8 | 5 | 1.0 | 0.078 | 0.715 |
No | 259 | 99.2 | 512 | 99.0 | ||
BMI categorized | ||||||
Underweight | 17 | 6.5 | 14 | 2.7 | 13.28 | 0.004 |
Normal weight | 42 | 16.1 | 128 | 24.8 | ||
Overweight | 117 | 44.8 | 227 | 44.0 | ||
Obesity | 85 | 32.6 | 147 | 28.5 |